Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 28.68
+0.13 (0.46%)
Jul 31, 2026, 3:00 PM CST
SHA:688062 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,486 | 1,528 | 1,193 | 1,651 | 2,491 | 96.54 |
Short-Term Investments | - | - | 35.87 | 35.26 | - | - |
Trading Asset Securities | 3.52 | - | 3.77 | 14.88 | 60.12 | - |
Cash & Short-Term Investments | 1,489 | 1,528 | 1,232 | 1,701 | 2,551 | 96.54 |
Cash Growth | 31.81% | 24.02% | -27.56% | -33.32% | 2542.47% | -82.38% |
Accounts Receivable | 127.52 | 99.79 | 38.34 | 17.51 | 0.07 | 0.14 |
Other Receivables | 126.11 | 123.3 | 100.05 | 112.27 | 82.65 | 33.01 |
Receivables | 253.63 | 223.09 | 138.39 | 129.78 | 82.73 | 33.15 |
Inventory | 197.92 | 187.9 | 211.68 | 159.3 | 79.05 | 40.11 |
Other Current Assets | 172.09 | 99.33 | 122.84 | 57.48 | 65.12 | 74.93 |
Total Current Assets | 2,113 | 2,039 | 1,705 | 2,048 | 2,778 | 244.74 |
Property, Plant & Equipment | 1,901 | 1,970 | 2,053 | 1,935 | 1,263 | 811.64 |
Long-Term Investments | 88.97 | 91.14 | 46.66 | 41.95 | 20.2 | 18.95 |
Goodwill | 118.77 | 118.77 | 118.77 | 118.77 | 118.77 | 118.77 |
Other Intangible Assets | 144.95 | 146.06 | 152.81 | 139.72 | 161.31 | 179.4 |
Long-Term Deferred Charges | 5.83 | 6.26 | 6.39 | 0.98 | 6.13 | 12.71 |
Other Long-Term Assets | 196.52 | 184.69 | 192.76 | 170.98 | 271.93 | 209.07 |
Total Assets | 4,568 | 4,556 | 4,276 | 4,455 | 4,619 | 1,595 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 150.98 | 197.38 | 100.23 | 62.32 | 45.21 | 39.69 |
Accrued Expenses | 97.72 | 145.03 | 150.64 | 138.12 | 82.25 | 57.53 |
Short-Term Debt | 1,353 | 1,147 | 921.6 | 209.27 | 100.14 | 10.82 |
Current Portion of Long-Term Debt | 301.98 | 183.8 | 113.65 | 1.59 | 0.6 | 0.15 |
Current Portion of Leases | - | 134.41 | 31.52 | 26.96 | 21.02 | 18.83 |
Current Income Taxes Payable | 19.74 | 2.34 | 2.39 | 3.34 | - | - |
Current Unearned Revenue | 303.52 | 288.59 | 36.01 | 13.52 | 36.65 | 63.53 |
Other Current Liabilities | 184.77 | 160.38 | 185.67 | 361.26 | 159.27 | 79.85 |
Total Current Liabilities | 2,412 | 2,259 | 1,542 | 816.39 | 445.14 | 270.41 |
Long-Term Debt | 1,455 | 1,341 | 1,006 | 887.72 | 492.12 | 132.05 |
Long-Term Leases | 155.56 | 165.94 | 142.97 | 167.11 | 160.57 | 172.72 |
Long-Term Unearned Revenue | 27.45 | 49.19 | 27.07 | 10.59 | 11.03 | 11.47 |
Other Long-Term Liabilities | 229.52 | 208.12 | 1.53 | - | - | - |
Total Liabilities | 4,279 | 4,023 | 2,720 | 1,882 | 1,109 | 586.65 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 399.6 | 399.6 | 399.6 | 399.6 | 399.6 | 299.7 |
Additional Paid-In Capital | - | 5,760 | 5,959 | 5,931 | 5,812 | 2,456 |
Retained Earnings | -6,007 | -5,765 | -4,795 | -3,751 | -2,698 | -1,743 |
Treasury Stock | -49.99 | -49.99 | - | - | - | - |
Comprehensive Income & Other | 5,764 | 4.45 | 5.08 | 4.8 | 1.56 | -2.6 |
Total Common Equity | 106.82 | 349.51 | 1,569 | 2,584 | 3,516 | 1,011 |
Minority Interest | 182.4 | 183.5 | -13.1 | -10.45 | -5.08 | -2.18 |
Shareholders' Equity | 289.21 | 533 | 1,556 | 2,573 | 3,511 | 1,009 |
Total Liabilities & Equity | 4,568 | 4,556 | 4,276 | 4,455 | 4,619 | 1,595 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,265 | 2,972 | 2,216 | 1,293 | 774.45 | 334.58 |
Net Cash (Debt) | -1,776 | -1,444 | -983.91 | 408.4 | 1,777 | -238.03 |
Net Cash Growth | - | - | - | -77.01% | - | - |
Net Cash Per Share | -4.46 | -3.62 | -2.46 | 1.02 | 4.54 | -0.79 |
Filing Date Shares Outstanding | 398.41 | 398.41 | 399.6 | 399.6 | 399.6 | 299.7 |
Total Common Shares Outstanding | 398.41 | 398.41 | 399.6 | 399.6 | 399.6 | 299.7 |
Working Capital | -299.1 | -220 | 163.47 | 1,231 | 2,333 | -25.68 |
Book Value Per Share | 0.27 | 0.88 | 3.93 | 6.47 | 8.80 | 3.37 |
Tangible Book Value | -156.9 | 84.68 | 1,297 | 2,325 | 3,236 | 712.64 |
Tangible Book Value Per Share | -0.39 | 0.21 | 3.25 | 5.82 | 8.10 | 2.38 |
Buildings | - | 754.31 | 753.02 | 181.83 | 3.06 | 3.06 |
Machinery | - | 1,221 | 1,206 | 653.69 | 440.39 | 420.08 |
Construction In Progress | - | 348.36 | 240.87 | 1,131 | 804.49 | 313.24 |